CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4-Reference-Cited by-同舟云学术

CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4

Published:1996-11 Issue:4 Volume:87 Page:745-756
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Endres Michael J,Clapham Paul R,Marsh Mark,Ahuja Ména,Turner Julie Davis,McKnight Aine,Thomas Jill F,Stoebenau-Haggarty Beth,Choe Sunny,Vance Patricia J,Wells Timothy N.C,Power Christine A,Sutterwala Shaheen S,Doms Robert W,Landau Nathaniel R,Hoxie James A

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference49 articles.

1. CC CKR5;Alkhatib;Science,1996

2. Cellular reservoirs of HIV-1 in the central nervous system of infected-individuals;Bagasra;AIDS,1996

3. A seven-transmembrane domain receptor involved in fusion and entry of T cell-tropic human immunodeficiency virus type 1 strains;Berson;J. Virol.,1996

4. Changes in the structure and function of the human thrombin receptor during receptor activation, internalization and recycling;Brass;J. Biol. Chem.,1994

5. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates;Choe;Cell,1996

Cited by 627 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCR4 influences PUFA desaturation and oxidative stress injury in experimental prostatitis mice by activating Fads2 via PPARγ;Free Radical Biology and Medicine;2024-10

2. Identifying and Assessing Putative Allosteric Sites and Modulators for CXCR4 Predicted through Network Modeling and Site Identification by Ligand Competitive Saturation;The Journal of Physical Chemistry B;2024-04-22

3. Selective synthesis of an elusive C-functional bis-cyclam and study of its inhibition of the CXCR4 chemokine receptor;Organic & Biomolecular Chemistry;2024

4. The development of potent, competitive CXCR4 antagonists for the prevention of cancer metastasis;Biochemical Pharmacology;2023-12

5. Development of N-Terminally Modified Variants of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability;Journal of Medicinal Chemistry;2023-11-08